Liquid Biopsy Cancer Screening
A liquid biopsy is a blood-based test designed to detect signs of cancer including tumor cell and cancer cell DNA. There are many advantages to a liquid biopsy including being non-invasive, higher availability of samples compared to tissue, suitability for longitudinal monitoring, and better sensitivity.
We offer comprehensive ctDNA screening support for clinical trials, retrospective studies, or method comparisons. Our team of experts can run any kitted solution.
Need a custom panel or solution? We have experience in whole exome sequencing, whole transcriptome sequencing, RNA-Seq, MRD, and bespoke solutions. We also offer bioinformatics and biostatistics support.
- TSO 500
- TST 170
- AVENIO Targeted
- AVENIO Expanded
- AVENIO Surveillance
- AVENIO CGP
- PGDx Elio
Schedule a consultation with our research team to discuss your specific needs.